XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 30, 2021
Cash flows from operating activities:        
Net income (loss) $ 55,229 $ 108,682 $ 60,731 $ 60,731
Adjustments to reconcile net income to net cash provided by operating activities:        
(Reversal of) provision for losses on accounts receivable (258) 367 1,338  
(Reversal) deferral of gain on sales to equity method investee, net (16) (39) 52  
Depreciation and amortization 69,943 57,512 53,881  
Deferred income tax benefit 18,701 13,968 18,413  
Income tax expense arising from restricted share vesting and stock options exercised (2,226) (526) (334)  
Stock-based compensation expense 7,100 6,587 9,059  
Income from equity method investment (21,384) (25,193) (14,782)  
Return on investment in affiliated company 9,800 14,700 4,900  
Gain on disposition of property and equipment (12,585) (40,322) (3,799)  
Return on investment in available-for-sale securities 0 0 (63)  
Changes in operating assets and liabilities:        
Receivables and advances (22,416) 39,465 (36,544)  
Prepaid expenses and other assets (3,997) (3,832) (710)  
Inventory and supplies (317) (193) (204)  
Insurance and claims accrual (3,542) (5,729) (31,653)  
Accounts payable and accrued expenses (9,191) (6,217) 12,933  
Net cash flows provided by operating activities 84,841 159,230 73,218  
Cash flows from investing activities:        
Acquisitions, net of cash acquired (107,934) (38,501) 0  
Other investments (2,204) (241) (13)  
Redemption of available-for-sale securities 0 0 1,508  
Acquisition of property and equipment (217,607) (100,468) (35,285)  
Proceeds from disposition of property and equipment 91,824 53,002 44,134  
Net cash flows (used) provided by investing activities (235,921) (86,208) 10,344  
Cash flows from financing activities:        
Change in checks outstanding in excess of bank balances 0 (216) (1,215)  
Cash dividend (5,781) (4,287) 0  
Proceeds from issuance of notes payable 154,093 95,151 0  
Proceeds from exercise of stock options 236 384 0  
Repayments of notes payable (30,390) (11,956) (14,397)  
Repayments of finance lease obligations (5,619) (5,516) (5,626)  
Proceeds under revolving credit facility 139,837 60,226 644,874  
Repayments under revolving credit facility (128,258) (60,226) (695,513)  
Payment of minimum tax withholdings on stock compensation (4,792) (1,606) (1,332)  
Payment of contingent liability (9,187) 0 0  
Common stock repurchased (25,430) (84,723) (10,348)  
Net cash flows provided by (used in) financing activities 84,709 (12,769) (83,557)  
Net change in cash and cash equivalents (66,371) 60,253 5  
Cash and cash equivalents at beginning of year 68,665 8,412 8,407 $ 8,407
Cash and cash equivalents at end of year 2,294 68,665 8,412  
Supplemental disclosure of cash flow information:        
Interest, net of capitalized interest 5,319 3,306 2,762  
Income taxes 4,186 16,653 10,236  
Non-cash transactions during the year for:        
Equipment acquired under finance leases 5,938 458 0  
Equipment acquired under operating leases 3,992 48,515 15,795  
Contingent consideration associated with acquisitions 11,802 16,210 0  
Other contingent liabilities $ (800) $ (1,000) $ (3,412)